Psychosocial factors and interleukin‐6 among women with advanced ovarian cancer
Open Access
- 13 June 2005
- Vol. 104 (2) , 305-313
- https://doi.org/10.1002/cncr.21147
Abstract
BACKGROUND: Relations among psychological stress, depression, social support, and interleukin‐6 (IL‐6, a proinflammatory cytokine) have been documented in humans and animals. Because elevated IL‐6 is associated with a poorer prognosis among ovarian cancer patients and has been implicated in the metastasis of ovarian cancer, the current study examined relations between psychosocial factors and IL‐6 among women with advanced‐stage ovarian cancer.METHODS: Sixty‐one ovarian cancer patients completed assessments of social support, distressed mood, and quality of life before surgery. Peripheral blood was drawn preoperatively, and the plasma was assayed for IL‐6. Ascites samples were also assayed for IL‐6 for a subset of patients.RESULTS: Both IL‐6 levels and distressed mood were elevated among patients. After statistically adjusting effects of age and disease stage, social attachment was associated with lower levels of IL‐6 in peripheral blood (P= 0.03), whereas poorer health‐related quality of life was associated with higher IL‐6 (Pvalues ranged from 0.01 to 0.03 on different measures). This pattern of relations was also found in the ascites. Moreover, IL‐6 levels in peripheral blood plasma correlated significantly with IL‐6 in the ascites (P< 0.001), suggesting that peripheral IL‐6 reflects IL‐6 levels at the site of the tumor.CONCLUSIONS: Results suggest that social support may play a protective role with respect to IL‐6 elevations, and IL‐6 may be an independent marker of health‐related quality of life among ovarian cancer patients. Processes involving IL‐6 represent possible pathways by which behavioral factors may contribute to disease outcomes among women with ovarian cancer. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 46 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionArchiv Fur Psychiatrie Und Nervenkrankheiten, 1997
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Spontaneous Release of Interleukin-6 by Primary Cultures of Lymphoid and Tumor Cell Populations Purified from Human Ovarian CarcinomaJournal of Interferon & Cytokine Research, 1995
- Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerCancer, 1994
- The acute phase responseImmunology Today, 1994
- Suicide associated with alfa-interferon therapy for chronic viral hepatitisJournal of Hepatology, 1994
- Immunological and Psychosocial Predictors of Disease Recurrence in Patients with Early-Stage Breast CancerBehavioral Medicine, 1991
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- The CES-D ScaleApplied Psychological Measurement, 1977